HIK.L vs. ^GSPC
HIK.L (Hikma Pharmaceuticals plc) is a stock, while ^GSPC (S&P 500 Index) is an index. Over the past 10 years, HIK.L returned -2.28%/yr vs 14.50%/yr for ^GSPC. At a 0.19 correlation, their price movements are largely independent.
Performance
HIK.L vs. ^GSPC - Performance Comparison
Loading charts...
Different Trading Currencies
HIK.L is traded in GBp, while ^GSPC is traded in USD. To make them comparable, the ^GSPC values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, HIK.L achieves a -3.15% return, which is significantly lower than ^GSPC's 11.24% return. Over the past 10 years, HIK.L has underperformed ^GSPC with an annualized return of -2.28%, while ^GSPC has yielded a comparatively higher 14.50% annualized return.
HIK.L
- 1D
- 3.11%
- 1M
- 3.47%
- YTD
- -3.15%
- 6M
- -5.58%
- 1Y
- -27.44%
- 3Y*
- -3.58%
- 5Y*
- -6.83%
- 10Y*
- -2.28%
^GSPC
- 1D
- 0.41%
- 1M
- 5.44%
- YTD
- 11.24%
- 6M
- 9.84%
- 1Y
- 28.25%
- 3Y*
- 18.03%
- 5Y*
- 13.60%
- 10Y*
- 14.50%
HIK.L vs. ^GSPC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HIK.L Hikma Pharmaceuticals plc | -3.15% | -19.62% | 14.90% | 18.37% | -28.40% | -10.43% | 28.87% | 18.12% | 54.10% | -39.17% |
^GSPC S&P 500 Index | 11.24% | 8.10% | 25.46% | 18.02% | -9.86% | 28.09% | 12.84% | 23.98% | -0.68% | 9.09% |
Correlation
The correlation between HIK.L and ^GSPC is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jul 3, 2007 | 0.19 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HIK.L vs. ^GSPC — Risk / Return Rank
HIK.L
^GSPC
HIK.L vs. ^GSPC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hikma Pharmaceuticals plc (HIK.L) and S&P 500 Index (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HIK.L | ^GSPC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.29 | ||
| Sortino ratioReturn per unit of downside risk | -4.15 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.46 | -0.62 |
| Calmar ratioReturn relative to maximum drawdown | -0.63 | 3.53 | -4.16 |
| Martin ratioReturn relative to average drawdown | -1.10 | 13.19 | -14.29 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HIK.L | ^GSPC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.83 | 2.46 | -3.29 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.25 | 0.86 | -1.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.07 | 0.80 | -0.87 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.58 | -0.26 |
Drawdowns
HIK.L vs. ^GSPC - Drawdown Comparison
The maximum HIK.L drawdown since its inception was -67.40%, which is greater than ^GSPC's maximum drawdown of -37.07%. Use the drawdown chart below to compare losses from any high point for HIK.L and ^GSPC.
Loading charts...
Drawdown Indicators
| HIK.L | ^GSPC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.40% | -37.07% | -30.33% |
Max Drawdown (1Y)Largest decline over 1 year | -43.67% | -8.03% | -35.64% |
Max Drawdown (3Y)Largest decline over 3 years | -47.40% | -22.15% | -25.25% |
Max Drawdown (5Y)Largest decline over 5 years | -54.46% | -22.15% | -32.31% |
Max Drawdown (10Y)Largest decline over 10 years | -67.40% | -26.01% | -41.39% |
Current DrawdownCurrent decline from peak | -37.14% | 0.00% | -37.14% |
Average DrawdownAverage peak-to-trough decline | -19.55% | -5.32% | -14.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.02% | 2.15% | +22.87% |
Volatility
HIK.L vs. ^GSPC - Volatility Comparison
Hikma Pharmaceuticals plc (HIK.L) has a higher volatility of 6.63% compared to S&P 500 Index (^GSPC) at 2.60%. This indicates that HIK.L's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HIK.L | ^GSPC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.63% | 2.60% | +4.03% |
Volatility (6M)Calculated over the trailing 6-month period | 26.21% | 8.20% | +18.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.98% | 11.52% | +21.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.78% | 15.85% | +11.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.64% | 18.15% | +13.49% |
Frequently Asked Questions
HIK.L and ^GSPC have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for HIK.L and ^GSPC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer